{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T10:14:30Z","timestamp":1769940870610,"version":"3.49.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"47","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.vaccine.2010.09.031","type":"journal-article","created":{"date-parts":[[2010,9,20]],"date-time":"2010-09-20T08:14:51Z","timestamp":1284970491000},"page":"7468-7475","source":"Crossref","is-referenced-by-count":88,"title":["GMP-grade pneumococcal whole-cell vaccine injected subcutaneously protects mice from nasopharyngeal colonization and fatal aspiration-sepsis"],"prefix":"10.1016","volume":"28","author":[{"given":"Ying-Jie","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciana","family":"Leite","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viviane Maimoni","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waldely de Oliveira","family":"Dias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celia","family":"Liberman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Fratelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Alderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Tate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Fran\u00e7ois","family":"Maisonneuve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Graca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabina","family":"Sayeed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudette M.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Porter","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Malley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"September (9693)","key":"10.1016\/j.vaccine.2010.09.031_bib0005","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0140-6736(09)61204-6","article-title":"Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates","volume":"374","author":"O\u2019Brien","year":"2009","journal-title":"Lancet"},{"issue":"June (1)","key":"10.1016\/j.vaccine.2010.09.031_bib0010","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1586\/14760584.1.1.65","article-title":"Pneumococcal conjugate vaccine: economic issues of the introduction of a new childhood vaccine","volume":"1","author":"Ray","year":"2002","journal-title":"Expert Rev Vaccines"},{"issue":"February (1)","key":"10.1016\/j.vaccine.2010.09.031_bib0015","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2217\/17460913.3.1.23","article-title":"Serotype-specific problems associated with pneumococcal conjugate vaccination","volume":"3","author":"Hanage","year":"2008","journal-title":"Future Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2010.09.031_bib0020","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/10408410600822942","article-title":"Streptococcus pneumoniae protein vaccine candidates: properties, activities and animal studies","volume":"32","author":"Tai","year":"2006","journal-title":"Crit Rev Microbiol"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2010.09.031_bib0025","doi-asserted-by":"crossref","first-page":"4870","DOI":"10.1128\/IAI.69.8.4870-4873.2001","article-title":"Intranasal immunization with killed unencapsulated whole cells prevents colonization and invasive disease by capsulated pneumococci","volume":"69","author":"Malley","year":"2001","journal-title":"Infect Immun"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2010.09.031_bib0030","doi-asserted-by":"crossref","first-page":"4290","DOI":"10.1128\/IAI.72.7.4290-4292.2004","article-title":"Multi-serotype protection of mice against pneumococcal colonization of the nasopharynx and middle ear by killed nonencapsulated cells given intranasally with a non-toxic adjuvant","volume":"72","author":"Malley","year":"2004","journal-title":"Infect Immun"},{"issue":"March (13)","key":"10.1016\/j.vaccine.2010.09.031_bib0035","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1073\/pnas.0501254102","article-title":"CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization","volume":"102","author":"Malley","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2010.09.031_bib0040","doi-asserted-by":"crossref","first-page":"e1000159","DOI":"10.1371\/journal.ppat.1000159","article-title":"Interleukin-17A mediates acquired immunity to pneumococcal colonization","volume":"4","author":"Lu","year":"2008","journal-title":"PLoS Pathog"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2010.09.031_bib0145","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1128\/CVI.00036-10","article-title":"Options for inactivation, adjuvant, and route of topical administration of a killed, unencapsulated pneumococcal whole-cell vaccine","volume":"17","author":"Lu","year":"2010","journal-title":"Clin Vaccine Immunol"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2010.09.031_bib0050","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1007\/s10295-008-0445-3","article-title":"Pneumococcal whole-cell vaccine: optimization of cell growth of unencapsulated Streptococcus pneumoniae in bioreactor using animal-free medium","volume":"35","author":"Liberman","year":"2008","journal-title":"J Ind Microbiol Biotechnol"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2010.09.031_bib0055","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1128\/IAI.01554-08","article-title":"Protection against pneumococcal colonization and fatal pneumonia by a trivalent conjugate of a fusion protein with the cell wall polysaccharide","volume":"77","author":"Lu","year":"2009","journal-title":"Infect Immun"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2010.09.031_bib0060","doi-asserted-by":"crossref","first-page":"e1000476","DOI":"10.1371\/journal.ppat.1000476","article-title":"Pneumococcal capsular polysaccharide structure predicts serotype prevalence","volume":"5","author":"Weinberger","year":"2009","journal-title":"PLoS Pathog"},{"issue":"February (6)","key":"10.1016\/j.vaccine.2010.09.031_bib0065","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.vaccine.2008.11.078","article-title":"Effect of the strength of adsorption of hepatitis B surface antigen to aluminum hydroxide adjuvant on the immune response","volume":"27","author":"Hansen","year":"2009","journal-title":"Vaccine"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2010.09.031_bib0070","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1086\/313632","article-title":"Rabies","volume":"30","author":"Plotkin","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2010.09.031_bib0075","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1128\/IAI.74.4.2187-2195.2006","article-title":"Antibody-independent, interleukin-17A-mediated, cross-serotype immunity to pneumococci in mice immunized intranasally with the cell wall polysaccharide","volume":"74","author":"Malley","year":"2006","journal-title":"Infect Immun"},{"issue":"April (4 (Suppl.))","key":"10.1016\/j.vaccine.2010.09.031_bib0080","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1038\/nm1213","article-title":"Mucosal immunity and vaccines","volume":"11","author":"Holmgren","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2010.09.031_bib0085","series-title":"Target product profile (TPP) for the advance market commitment (AMC) for pneumococcal conjugate vaccines","author":"WHO","year":"2008"},{"issue":"Suppl. A","key":"10.1016\/j.vaccine.2010.09.031_bib0090","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/jac\/18.Supplement_A.35","article-title":"Some aspects of the pneumococcal carrier state","volume":"18","author":"Austrian","year":"1986","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.vaccine.2010.09.031_bib0095","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1086\/313608","article-title":"Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I [in process citation]","volume":"30","author":"Hausdorff","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"October (14)","key":"10.1016\/j.vaccine.2010.09.031_bib0100","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJMoa035060","article-title":"A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection","volume":"349","author":"Klugman","year":"2003","journal-title":"N Engl J Med"},{"issue":"March\u2013April (9465)","key":"10.1016\/j.vaccine.2010.09.031_bib0105","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0140-6736(05)71876-6","article-title":"Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial","volume":"365","author":"Cutts","year":"2005","journal-title":"Lancet"},{"issue":"April (16)","key":"10.1016\/j.vaccine.2010.09.031_bib0110","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1001\/jama.297.16.1784","article-title":"Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage","volume":"297","author":"Singleton","year":"2007","journal-title":"JAMA"},{"issue":"January (3)","key":"10.1016\/j.vaccine.2010.09.031_bib0115","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1056\/NEJMoa0800836","article-title":"Effect of pneumococcal conjugate vaccine on pneumococcal meningitis","volume":"360","author":"Hsu","year":"2009","journal-title":"N Engl J Med"},{"issue":"March (17)","key":"10.1016\/j.vaccine.2010.09.031_bib0120","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/S0264-410X(99)00530-7","article-title":"Immunization of healthy adults with a single recombinant pneumococcal surface protein A (PspA) variant stimulates broadly cross-reactive antibodies to heterologous PspA molecules","volume":"18","author":"Nabors","year":"2000","journal-title":"Vaccine"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2010.09.031_bib0125","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1086\/317602","article-title":"Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA","volume":"182","author":"Briles","year":"2000","journal-title":"J Infect Dis"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2010.09.031_bib0130","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1084\/jem.20071168","article-title":"Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies","volume":"205","author":"Giefing","year":"2008","journal-title":"J Exp Med"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2010.09.031_bib0135","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.micinf.2005.10.020","article-title":"Induction of systemic and mucosal immune response and decrease in Streptococcus pneumoniae colonization by nasal inoculation of mice with recombinant lactic acid bacteria expressing pneumococcal surface antigen A","volume":"8","author":"Oliveira","year":"2006","journal-title":"Microbes Infect"},{"issue":"5","key":"10.1016\/j.vaccine.2010.09.031_bib0140","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1128\/IAI.68.5.3028-3033.2000","article-title":"Immunization of mice with combinations of pneumococcal virulence proteins elicits enhanced protection against challenge with Streptococcus pneumoniae","volume":"68","author":"Ogunniyi","year":"2000","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10013411?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10013411?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T22:40:58Z","timestamp":1559688058000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10013411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":28,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0264410X10013411"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.09.031","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}